Christian authored Catenion's Commentary, "The Challenge for Japan's Pharmaceutical Top Twenty" which addresses the question whether the Japanese pharmaceutical industry can become competitive, as well as "Zero Base R&D". Christian also co–authored Catenion's most recent commentary, "Risk Profiles of Corporate Portfolio Strategies" and the previous Commentary "Recombinant Innovation Management (RIM) – How to Stimulate Breakthrough Innovation within Large R&D Organisations".

Read more of Christian's Commentaries...

Christian Elze

Christian Elze, Senior Partner

Senior Partner
London, United Kingdom

Email: christian.elze@catenion.com





Christian Elze is a founding Senior Partner of Catenion who lives in London. After graduating from the London School of Economics, he sold machine tools in the Soviet Union and Mexico, worked on a development project in North Yemen and held a position in the controller's department of a German bank. After obtaining his MBA from Columbia University in 1984, he started his consulting career in Sao Paolo and eventually ran the European healthcare practice of Mercer Management Consulting out of Paris. In 2003, he co–founded Catenion.

Christian has helped numerous clients in the pharmaceutical, medical products and other industries develop competitive strategies and create winning organisations.

He has a keen interest in creativity and applied epistemology: What we can know, how we know it and how knowledge is transformed into innovation. He has extensively spoken and written on the future of Europe's healthcare systems and the future of work.

From 2001 to 2003, Christian was a member of the Supervisory Board of Epigenomics AG in Berlin.

Christian holds a BSc in Economics from the London School of Economics and an MBA from Columbia University.

Christian has lived and worked in a dozen countries in Europe and the Americas and is a fluent speaker of English, French, German, Italian, Portuguese, Russian and Spanish. He is currently studying Japanese.